Recent progress in radiofluorination of peptides for PET molecular imaging

Current Organic Synthesis

Volumn 8, Issue 4, 2011, Pages 584-592

  Liu, Shuanglong ^a   Shen, Bin ^a   Chin, Frederick T ^a   Cheng, Zhen ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

18f; Molecular imaging; Peptide; Positron emission tomography; Radiofluorination

Indexed keywords

EID: 79959998224     PISSN: 15701794     EISSN: None     Source Type: Journal    
DOI: 10.2174/157017911796117197     Document Type: Article

References (68)

1. Paans, A.M.; Vaalburg, W.; Woldring, M.G., A comparison of the sensitivity of PET and NMR for in vivo quantitative metabolic imaging. Eur. J. Nucl. Med., 1985, 11(2-3), 73-75.
2. 18Ffluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors. Clin. Cancer Res., 2010, 16(3), 978- 985
3. 18F-labeled metallopeptides. J. Nucl. Med., 2009, 50(11), 1865-1872
4. 18F for PET imaging of integrin expression. Bioconjug. Chem., 2009, 20(12), 2342-2347.
5. Schottelius, M.; Wester, H.J., Molecular imaging targeting peptide receptors. Methods, 2009, 48(2), 161-177.
6. de Jong, M.; Kwekkeboom, D.; Valkema, R.; Krenning, E.P., Radiolabelled peptides for tumour therapy: current status and future directions. Plenary lecture at the EANM 2002. Eur J Nucl Med Mol Imaging, 2003, 30(3), 463-469.
7. 11C-labelled enkephalin peptides in the brain, pituitary and plasma of rhesus monkeys. Regul. Pept., 1986, 16(1), 1-13.
8. Lucignani, G., Labeling peptides with PET radiometals: Vulcan's forge. Eur J. Nucl. Med. Mol. Imag., 2008, 35(1), 209-215.
9. 18F-galacto-RGD in cancer patients. J. Nucl. Med., 2005, 46(8), 1333-1341
10. 18F]Galacto-RGD. PLoS Med., 2005, 2(3), e70;
11. 18F-labelled, carbohydrated analogue of octreotide. Eur. J. Nucl. Med. Mol. Imag., 2003, 30(1), 117-122.
12. 18F, 64Cu, and 68Ga Labeled RGD-Bombesin Heterodimeric Peptides for PET Imaging of Breast Cancer. Bioconjug. Chem., 2009, 20, 1016-1025.
13. 18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates. Bioconjug. Chem., 2004, 15(1), 61-69.
14. 18F-labeled Mel-14 F(ab')2 fragment in normal dogs. Nucl. Med. Biol., 1994, 21(7), 911-919
15. Zalutsky, M.R.; Garg, P.K.; Johnson, S.H.; Utsunomiya, H.; Coleman, R.E., Fluorine-18- antimyosin monoclonal antibody fragments: preliminary investigations in a canine myocardial infarct model. J. Nucl. Med., 1992, 33(4), 575-580.
16. Kilbourn, M.R.; Dence, C.S.; Welch, M.J.; Mathias, C.J., Fluorine-18 labeling of proteins. J. Nucl. Med., 1987, 28(4), 462-470.
17. 18F](fluoromethyl) benzoate. Appl. Radiat. Isot., 1997, 48(2), 169-173
18. 18F]-N-succinimidyl 4-(fluoromethyl)benzoate for protein labeling. Appl. Radiat. Isot., 1994, 45(12), 1155-1163.
19. Block, D.; Coenen, H.H.; Stocklin, G., Nca F-18-Fluoroacylation Via Fluorocarboxylic Acid-Esters. J. Labelled Compd. Rad., 1988, 25(2), 185-200.
20. Guhlke, S.; Coenen, H.H.; Stocklin, G., Fluoroacylation Agents Based on Small Nca [F-18] Fluorocarboxylic Acids. Appl. Radiat. Isotopes, 1994, 45(6), 715-727.
21. Wester, H.J.; Hamacher, K.; Stocklin, G., A comparative study of NCA fluorine-18 labeling of proteins via acylation and photochemical conjugation. Nucl. Med. Biol., 1996, 23(3), 365-372.
22. 3 integrin antagonists: a new class of tracers for tumor targeting. J. Nucl. Med., 1999, 40(6), 1061-1071.
23. Haubner, R.; Wester, H.J.; Burkhart, F.; Senekowitsch-Schmidtke, R.; Weber, W.; Goodman, S.L.; Kessler, H.; Schwaiger, M., Glycosylated RGDcontaining peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J. Nucl. Med., 2001, 42(2), 326-336
24. 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res., 2001, 61(5), 1781-1785.
25. 18F]labelled peptides for positron emission tomography. Bioorg. Med. Chem. Lett., 2000, 10(14), 1501-1503;
26. Vaidyanathan, G.; Bigner, D.D.; Zalutsky, M.R., Fluorine-18-labeled monoclonal antibody fragments: a potential approach for combining radioimmunoscintigraphy and positron emission tomography. J. Nucl. Med., 1992, 33(8), 1535-1541
27. 18F]fluorobenzoate. Int. J. Rad. Appl. Instrum. B. 1992, 19(3), 275-281.
28. 18F]fluorobenzoate. Appl. Radiat. Isot., 2003, 59(1), 43-48.
29. 18F]SFB). Appl. Radiat. Isot., 2005, 63(3), 329-332.
30. Tang, G.; Zeng, W.B.; Yu, M.X.; Kabalka, G., Facile synthesis of Nsuccinimidyl 4-[F-18]fluorobenzoate ([F-18]SFB) for protein labeling. J. Labelled Compd. Rad., 2008, 51(1-2), 68-71.
31. 18F-labeled-α-melanocyte-stimulating hormone analog. J. Nucl. Med., 2007, 48(6), 987-994.
32. 18Flabeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis. Nucl. Med. Biol., 2004, 31(2), 179-189
33. 18Fand 64Cu-labeled RGD peptide. Bioconjug. Chem., 2004, 15(1), 41-49.
34. 18F-labelled annexin V: a PET tracer for apoptosis imaging. Eur J Nucl Med Mol Imaging, 2004, 31(4), 469-474
35. 18F-annexin V as a PET imaging agent in an animal model of apoptosis. J. Nucl. Med., 2005, 46(4), 658-666.
36. Fredriksson, A.; Johnstrom, P.; Stone-Elander, S.; Jonasson, P.; Nygren, P.A.; Ekberg, K.; Johansson, B.L.; Wahren, J., Labeling of human C-peptide by conjugation with N-succinimidyl-4-[F-18]fluorobenzoate. J. Labelled Compd. Rad., 2001, 44(7), 509-519.
37. 18F-labelled endothelin-1 reveals prevention of binding to cardiac receptors owing to tissue-specific clearance by ET B receptors in vivo. Br. J. Pharmacol., 2005, 144(1), 115-122.
38. 18F-labeled neurotensin(8-13) analogs. Nucl. Med. Biol., 2002, 29(1), 61-72.
39. 18F. J. Labelled Compd. Rad., 1989, 26, 287-289.
40. 18F-labeling agent. Bioconjug. Chem., 2003, 14(6), 1253-1259.
41. 18F]fluoropyridine-based maleimide reagent for the labeling of peptides and proteins. Bioconjug. Chem., 2005, 16(2), 406-420.
42. 3 integrin expression. J. Nucl. Med., 2006, 47(7), 1172-1180.
43. Marans, N.S.; Sommer, L.H.; Whitmore, F.C., Preparation of Organofluorosilanes Using Aqueous Hydrofluoric Acid. J. Amer. Chem. Soc., 1951, 73(11), 5127-5130.
44. Walsh, J.C.; Akhoon, K.M.; Satyamurthy, N.; Barrio, J.R.; Phelps, M.E.; Gambhir, S.S.; Toyokuni, T., Application of silicon-fluoride chemistry to fluorine-18 labeling agents for biomolecules: a preliminary note. J. Labelled Compd. Rad., 1999, 42, S1-S3;
45. 18F]fluorotrimethylsilane. Int. J. Appl. Radiat. Isot., 1985, 36(5), 375-378.
46. Nelson, T.D.; Crouch, R.D., Selective deprotection of silyl ethers. Synthesis- Stuttgart, 1996, (9), 1031-1069.
47. 18F-labeled silicon-based PET tracers and their hydrolytic stability: experimental data and theoretical calculations (PET = positron emission tomography). Chemistry, 2009, 15(15), 3736-3743.
48. 18F-labeling, and in vitro and in vivo studies of bombesin peptides modified with silicon-based building blocks. Bioconjug. Chem., 2008, 19(9), 1871-1879.
49. 18F]-labeled aryltrifluoroborate radiotracers: in vivo positron emission tomography imaging of stable aryltrifluoroborate clearance in mice. J. Am. Chem. Soc., 2008, 130(36), 12045-12055.
50. 18F radiolabeling for PET. J. Nucl. Med., 2009, 50(6), 991-998.
51. 18Flabeled RGD and octreotide analogs. J. Nucl. Med., 2004, 45(5), 892-902.
52. 18F using a hydrazoneformation method. Bioconjug. Chem., 2005, 16(5), 1329-1333.
53. Harki, D.A.; Satyamurthy, N.; Stout, D.B.; Phelps, M.E.; Dervan, P.B., In vivo imaging of pyrrole-imidazole polyamides with positron emission tomography. Proc. Natl. Acad. Sci. USA, 2008, 105(35), 13039-13044.
54. 18F]fluorobenzaldehyde via oxime chemistry. Mol. Imag. Biol., 2008, 10(4), 177-181
55. 18F-labeled protein scaffold molecules. J. Nucl. Med., 2008, 49(5), 804-813.
56. 18F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography. Clin. Cancer Res., 2004, 10(11), 3593-3606.
57. 18F]FDG. Bioconjug. Chem., 2009, 20(3), 432-436.
58. 18F]glycosylation using Koenigs-Knorr conditions: a comparative study. J. Label. Compd. Radiopharm., 2006, 49, 101-108.
59. 18Fglycosylation of peptides. Bioconjug. Chem., 2007, 18(1), 254-262.
60. Kolb, H.C.; Finn, M.G.; Sharpless, K.B., Click Chemistry: Diverse Chemical Function from a Few Good Reactions. Angew. Chem. Int. Ed. Engl., 2001, 40(11), 2004-2021
61. Rostovtsev, V.V.; Green, L.G.; Fokin, V.V.; Sharpless, K.B., A stepwise huisgen cycloaddition process: copper(I)- catalyzed regioselective ligation of azides and terminal alkynes. Angew. Chem. Int. Ed. Engl., 2002, 41(14), 2596-2599.
62. Gopi, H.N.; Tirupula, K.C.; Baxter, S.; Ajith, S.; Chaiken, I.M., Click chemistry on azidoproline: high-affinity dual antagonist for HIV-1 envelope glycoprotein gp120. Chem MedChem, 2006, 1(1), 54-57
63. Lin, P.C.; Ueng, S.H.; Tseng, M.C.; Ko, J.L.; Huang, K.T.; Yu, S.C.; Adak, A.K.; Chen, Y.J.; Lin, C.C., Site-specific protein modification through Cu(I)-catalyzed 1,2,3- triazole formation and its implementation in protein microarray fabrication. Angew. Chem. Int. Ed. Engl., 2006, 45(26), 4286-4290
64. Link, A.J.; Tirrell, D.A., Cell surface labeling of Escherichia coli via copper(I)- catalyzed [3+2] cycloaddition. J. Am. Chem. Soc., 2003, 125(37), 11164- 11165.
65. Marik, J.; Sutcliffe, J.L., Click for PET: rapid preparation of [F-18]fluoropeptides using Cu-I catalyzed 1,3-dipolar cycloaddition. Tetrahedron Lett., 2006, 47(37), 6681-6684.
66. Sirion, U.; Kim, H.J.; Lee, J.H.; Seo, J.W.; Lee, B.S.; Lee, S.J.; Oh, S.J.; Chi, D.Y., An efficient F-18 labeling method for PET study: Huisgen 1,3-dipolar cycloaddition of bioactive substances and F-18-labeled compounds. Tetrahedron Lett., 2007, 48(23), 3953-3957.
67. 3 expression. Bioconjug. Chem., 2007, 18(6), 1987-1994.
68. 18F-glycopeptides as effective imaging probes for positron emission tomography. Angew. Chem. Int. Ed. Engl., 2010, 49(5), 976-979.